Healthcare Sector Stocks
The Healthcare sector has a total of 1049 stocks, with a combined market cap of $9.23 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.31.
Market Cap
9.23T
Revenue
4.67T
Profits
191B
PE Ratio
48.31
Profit Margin
4.09%
Dividend Yield
0.39%
1049 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.05T | 0.33% | 855,310 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 626.96B | 1.43% | 2,839,396 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 488.06B | 1.38% | 1,868,648 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 360.97B | 2.76% | 4,816,281 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 343.72B | 3.23% | 4,846,829 | 450.53B |
| 6 | NVS | Novartis AG | 273.65B | 0.43% | 1,458,425 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 244.41B | 0.28% | 1,304,369 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 243.45B | 0.99% | 825,103 | 46.34B |
| 9 | AMGN | Amgen Inc. | 225.21B | 2.24% | 984,827 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 186.98B | 2.51% | 2,686,178 | 30.46B |
| 11 | ABT | Abbott Laboratories | 171.97B | 0.90% | 4,081,486 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 170.48B | 0.81% | 6,374,798 | 50.34B |
| 13 | PFE | Pfizer Inc. | 160.56B | 1.26% | 15,184,145 | 63.70B |
| 14 | DHR | Danaher Corporation | 154.90B | 1.32% | 2,030,279 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 150.53B | 2.57% | 1,078,753 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 129.75B | 1.72% | 662,136 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 120.70B | -0.82% | 5,125,846 | 49.19B |
| 18 | MDT | Medtronic plc | 113.12B | 0.77% | 19,028,722 | 37.54B |
| 19 | CVS | CVS Health Corporation | 111.71B | -0.52% | 7,063,446 | 412.65B |
| 20 | MCK | McKesson Corporation | 109.86B | 1.29% | 245,198 | 410.98B |
| 21 | SYK | Stryker Corporation | 106.50B | 0.24% | 876,208 | 25.84B |
| 22 | HCA | HCA Healthcare, Inc. | 97.79B | 1.50% | 429,390 | 78.01B |
| 23 | SNY | Sanofi | 95.74B | -0.21% | 1,398,729 | 55.89B |
| 24 | GSK | GSK plc | 92.03B | 0.15% | 6,516,499 | 44.05B |
| 25 | ELV | Elevance Health, Inc. | 90.02B | 3.52% | 1,471,584 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 88.23B | 12.18% | 23,484,047 | 2.23B |
| 27 | CI | The Cigna Group | 74.79B | 0.71% | 495,843 | 282.38B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 74.42B | 0.77% | 280,299 | 15.53B |
| 29 | COR | Cencora, Inc. | 62.05B | 1.19% | 372,913 | 332.77B |
| 30 | BSX | Boston Scientific Corporation | 61.58B | 1.07% | 7,040,319 | 21.00B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 59.55B | 1.03% | 1,427,240 | 28.42B |
| 32 | NTRA | Natera, Inc. | 57.85B | 2.70% | 701,444 | 2.71B |
| 33 | CAH | Cardinal Health, Inc. | 55.22B | -0.20% | 494,934 | 254.25B |
| 34 | HUM | Humana Inc. | 52.30B | 12.50% | 3,665,546 | 145.68B |
| 35 | ARGX | argenx SE | 51.18B | 0.34% | 372,419 | 5.32B |
| 36 | BDX | Becton, Dickinson and Company | 49.93B | 0.30% | 552,681 | 22.48B |
| 37 | EW | Edwards Lifesciences Corporation | 48.63B | 0.14% | 2,065,433 | 6.51B |
| 38 | A | Agilent Technologies, Inc. | 48.27B | 1.81% | 798,383 | 7.37B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 48.16B | 5.30% | 11,213,440 | 17.32B |
| 40 | VEEV | Veeva Systems Inc. | 47.85B | 3.76% | 982,365 | 3.46B |
| 41 | MDLN | Medline Inc. | 47.71B | 1.54% | 3,510,253 | 29.94B |
| 42 | IQV | IQVIA Holdings Inc. | 43.04B | 1.00% | 554,379 | 16.98B |
| 43 | WAT | Waters Corporation | 42.70B | 1.28% | 618,825 | 4.64B |
| 44 | ILMN | Illumina, Inc. | 41.62B | 4.18% | 1,140,463 | 4.49B |
| 45 | RVMD | Revolution Medicines, Inc. | 40.96B | 1.59% | 1,447,835 | - |
| 46 | IDXX | IDEXX Laboratories, Inc. | 40.85B | 1.04% | 207,837 | 4.55B |
| 47 | ONC | BeOne Medicines AG | 40.41B | 1.49% | 103,975 | 6.13B |
| 48 | HLN | Haleon plc | 40.32B | 0.59% | 8,739,734 | 14.80B |
| 49 | BIIB | Biogen Inc. | 33.29B | 3.15% | 484,119 | 10.03B |
| 50 | RPRX | Royalty Pharma plc | 32.72B | 1.25% | 1,488,938 | 2.54B |
| 51 | CNC | Centene Corporation | 32.60B | 2.25% | 1,861,665 | 180.30B |
| 52 | RMD | ResMed Inc. | 32.41B | 1.64% | 489,460 | 5.65B |
| 53 | DXCM | DexCom, Inc. | 31.61B | -0.77% | 1,537,547 | 4.97B |
| 54 | ALC | Alcon Inc. | 31.39B | 1.52% | 918,693 | 10.86B |
| 55 | MTD | Mettler-Toledo International Inc. | 31.10B | 1.47% | 110,454 | 4.13B |
| 56 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.93B | 2.96% | 527,713 | 4.80B |
| 57 | ZTS | Zoetis Inc. | 30.71B | 1.68% | 1,642,321 | 9.53B |
| 58 | GEHC | GE HealthCare Technologies Inc. | 29.59B | 2.01% | 1,420,371 | 21.27B |
| 59 | WST | West Pharmaceutical Services, Inc. | 25.99B | 1.68% | 251,333 | 3.33B |
| 60 | LH | Labcorp Holdings Inc. | 25.61B | 0.51% | 344,935 | 14.35B |
| 61 | DGX | Quest Diagnostics Incorporated | 25.61B | 0.52% | 308,840 | 11.56B |
| 62 | ROIV | Roivant Sciences Ltd. | 25.47B | 3.05% | 2,610,002 | 7.53M |
| 63 | BNTX | BioNTech SE | 24.32B | 5.16% | 963,602 | 3.03B |
| 64 | UTHR | United Therapeutics Corporation | 23.57B | 3.14% | 310,124 | 3.15B |
| 65 | PHG | Koninklijke Philips N.V. | 23.42B | -0.37% | 2,851,822 | 20.18B |
| 66 | INCY | Incyte Corporation | 22.96B | 0.46% | 589,901 | 5.82B |
| 67 | GH | Guardant Health, Inc. | 22.42B | 0.93% | 896,736 | 1.18B |
| 68 | INSM | Insmed Incorporated | 21.92B | -0.09% | 1,420,869 | 1.14B |
| 69 | GMAB | Genmab A/S | 21.57B | 2.25% | 1,587,707 | 4.13B |
| 70 | THC | Tenet Healthcare Corporation | 21.39B | 1.94% | 237,751 | 21.81B |
| 71 | STE | STERIS plc | 20.94B | 1.92% | 269,401 | 6.04B |
| 72 | VTRS | Viatris Inc. | 20.27B | 1.20% | 5,312,795 | 14.74B |
| 73 | MEDP | Medpace Holdings, Inc. | 17.29B | 2.76% | 90,891 | 2.78B |
| 74 | RVTY | Revvity, Inc. | 17.28B | 1.79% | 735,814 | 2.91B |
| 75 | ZBH | Zimmer Biomet Holdings, Inc. | 16.98B | 0.16% | 837,682 | 8.51B |
| 76 | ASND | Ascendis Pharma A/S | 15.08B | 3.11% | 554,721 | 1.20B |
| 77 | SOLV | Solventum Corporation | 14.95B | 1.64% | 373,469 | 8.31B |
| 78 | EXEL | Exelixis, Inc. | 14.91B | 1.95% | 1,257,626 | 2.44B |
| 79 | CRL | Charles River Laboratories International, Inc. | 14.50B | 1.90% | 366,343 | 4.00B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 14.48B | 0.82% | 561,086 | 3.37B |
| 81 | JAZZ | Jazz Pharmaceuticals plc | 14.37B | -0.50% | 862,312 | 4.60B |
| 82 | SMMT | Summit Therapeutics Inc. | 13.78B | 0.35% | 4,014,868 | - |
| 83 | BTSG | BrightSpring Health Services, Inc. | 13.48B | 1.65% | 837,674 | 14.37B |
| 84 | CORT | Corcept Therapeutics Incorporated | 13.12B | 2.42% | 299,270 | 830.81M |
| 85 | TEM | Tempus AI, Inc. | 12.88B | 3.02% | 4,739,396 | 1.43B |
| 86 | BBIO | BridgeBio Pharma, Inc. | 12.82B | 0.80% | 1,029,941 | 713.07M |
| 87 | ICLR | ICON Public Limited Company | 12.68B | -0.06% | 446,106 | 8.29B |
| 88 | HALO | Halozyme Therapeutics, Inc. | 12.68B | 1.69% | 1,025,358 | 1.66B |
| 89 | BAX | Baxter International Inc. | 12.63B | 2.20% | 1,328,744 | 11.47B |
| 90 | PEN | Penumbra, Inc. | 12.57B | 0.47% | 360,917 | 1.50B |
| 91 | EHC | Encompass Health Corporation | 12.25B | 1.30% | 308,653 | 6.21B |
| 92 | SNN | Smith & Nephew plc | 11.47B | 0.95% | 659,929 | 6.30B |
| 93 | ELAN | Elanco Animal Health Incorporated | 11.44B | 1.60% | 1,143,976 | 5.02B |
| 94 | DVA | DaVita Inc. | 11.43B | 1.24% | 163,750 | 14.01B |
| 95 | TECH | Bio-Techne Corporation | 11.36B | 0.03% | 1,391,657 | 1.22B |
| 96 | IBRX | ImmunityBio, Inc. | 11.30B | 7.57% | 13,989,103 | 165.79M |
| 97 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.00B | -0.16% | 200,280 | 1.28B |
| 98 | FMS | Fresenius Medical Care AG | 10.99B | 0.81% | 804,217 | 22.19B |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 10.64B | 0.15% | 973,888 | 3.41B |
| 100 | TXG | 10x Genomics, Inc. | 10.61B | 5.38% | 2,753,030 | 616.91M |
| 101 | AVTR | Avantor, Inc. | 10.61B | 1.88% | 2,609,697 | 6.56B |
| 102 | PCVX | Vaxcyte, Inc. | 10.57B | 9.24% | 2,333,728 | - |
| 103 | RDY | Dr. Reddy's Laboratories Limited | 10.53B | 2.34% | 950,521 | 3.50B |
| 104 | UHS | Universal Health Services, Inc. | 10.52B | 1.58% | 183,370 | 18.11B |
| 105 | COO | The Cooper Companies, Inc. | 10.30B | -0.22% | 1,716,738 | 4.24B |
| 106 | MOH | Molina Healthcare, Inc. | 10.30B | 0.96% | 291,988 | 42.47B |
| 107 | OSCR | Oscar Health, Inc. | 10.26B | 0.54% | 3,406,899 | 15.32B |
| 108 | TWST | Twist Bioscience Corporation | 10.15B | 6.45% | 2,341,983 | 431.80M |
| 109 | ALGN | Align Technology, Inc. | 10.08B | 0.60% | 687,548 | 4.14B |
| 110 | GMED | Globus Medical, Inc. | 10.08B | 2.36% | 499,256 | 3.14B |
| 111 | ENSG | The Ensign Group, Inc. | 10.02B | 1.12% | 82,852 | 5.49B |
| 112 | KRYS | Krystal Biotech, Inc. | 9.83B | 1.45% | 112,261 | 440.48M |
| 113 | BIO | Bio-Rad Laboratories, Inc. | 9.81B | 1.84% | 76,853 | 2.59B |
| 114 | RGEN | Repligen Corporation | 9.75B | 5.41% | 756,271 | 785.10M |
| 115 | GKOS | Glaukos Corporation | 9.73B | 2.36% | 783,748 | 612.84M |
| 116 | KYMR | Kymera Therapeutics, Inc. | 9.55B | 5.12% | 730,234 | 105.00M |
| 117 | QGEN | Qiagen N.V. | 9.41B | 2.17% | 689,347 | 2.10B |
| 118 | HSIC | Henry Schein, Inc. | 9.32B | -1.15% | 614,879 | 13.60B |
| 119 | PTGX | Protagonist Therapeutics, Inc. | 9.32B | 2.92% | 477,495 | 281.99M |
| 120 | PODD | Insulet Corporation | 9.31B | -0.14% | 471,861 | 3.05B |
| 121 | BRKR | Bruker Corporation | 8.94B | 1.31% | 737,241 | 3.50B |
| 122 | AXSM | Axsome Therapeutics, Inc. | 8.85B | -0.63% | 536,301 | 776.57M |
| 123 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.83B | 2.96% | 866,831 | 669.50M |
| 124 | CYTK | Cytokinetics, Incorporated | 8.74B | 1.40% | 481,381 | 67.67M |
| 125 | CAI | Caris Life Sciences, Inc. | 8.37B | 7.75% | 2,762,187 | 989.61M |
| 126 | HNGE | Hinge Health, Inc. | 8.27B | 4.57% | 1,290,899 | 720.06M |
| 127 | SYRE | Spyre Therapeutics, Inc. | 7.98B | 6.82% | 596,554 | - |
| 128 | TGTX | TG Therapeutics, Inc. | 7.78B | 2.87% | 859,013 | 799.54M |
| 129 | ATR | AptarGroup, Inc. | 7.70B | -0.61% | 223,737 | 3.93B |
| 130 | HQY | HealthEquity, Inc. | 7.69B | -0.13% | 315,755 | 1.36B |
| 131 | ABVX | ABIVAX Société Anonyme | 7.62B | -1.18% | 649,654 | 5.33M |
| 132 | IONS | Ionis Pharmaceuticals, Inc. | 7.55B | 4.86% | 3,614,085 | 874.09M |
| 133 | PRAX | Praxis Precision Medicines, Inc. | 7.28B | -1.11% | 335,907 | 7.46M |
| 134 | HIMS | Hims & Hers Health, Inc. | 7.18B | 9.69% | 10,179,931 | 2.58B |
| 135 | PACS | PACS Group, Inc. | 6.93B | 0.14% | 438,257 | 5.55B |
| 136 | AMRX | Amneal Pharmaceuticals, Inc. | 6.93B | 1.22% | 527,192 | 3.12B |
| 137 | ALKS | Alkermes plc | 6.83B | 1.45% | 1,040,971 | 1.67B |
| 138 | IOVA | Iovance Biotherapeutics, Inc. | 6.68B | 10.74% | 12,986,080 | 324.97M |
| 139 | LNTH | Lantheus Holdings, Inc. | 6.55B | 0.17% | 757,682 | 1.56B |
| 140 | GRFS | Grifols, S.A. | 6.54B | 0.88% | 241,292 | 8.48B |
| 141 | CHE | Chemed Corporation | 6.52B | 0.53% | 78,364 | 2.60B |
| 142 | GRAL | GRAIL, Inc. | 6.33B | 6.79% | 558,069 | 165.26M |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.29B | 1.87% | 1,152,831 | 239.92M |
| 144 | IMVT | Immunovant, Inc. | 6.29B | 0.59% | 715,708 | - |
| 145 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.21B | 1.03% | 273,730 | 840.85M |
| 146 | BLTE | Belite Bio, Inc | 6.21B | 1.06% | 81,823 | - |
| 147 | KOD | Kodiak Sciences Inc. | 6.19B | 4.76% | 1,210,624 | - |
| 148 | BLCO | Bausch + Lomb Corporation | 6.16B | 0.64% | 94,897 | 5.32B |
| 149 | LGND | Ligand Pharmaceuticals Incorporated | 6.06B | 3.05% | 60,991 | 290.54M |
| 150 | CGON | CG Oncology, Inc. | 5.70B | 1.62% | 227,516 | 6.23M |
| 151 | MIRM | Mirum Pharmaceuticals, Inc. | 5.68B | 7.57% | 627,346 | 618.07M |
| 152 | RDNT | RadNet, Inc. | 5.59B | 4.22% | 334,379 | 2.27B |
| 153 | MANE | Veradermics, Incorporated | 5.57B | 5.19% | 778,338 | - |
| 154 | ERAS | Erasca, Inc. | 5.54B | 2.46% | 5,164,016 | - |
| 155 | MMED | MiniMed Group, Inc. | 5.52B | -0.83% | 12,270,340 | 3.22B |
| 156 | HAE | Haemonetics Corporation | 5.46B | 0.44% | 605,006 | 1.35B |
| 157 | ORKA | Oruka Therapeutics, Inc. | 5.38B | 5.20% | 596,876 | - |
| 158 | COGT | Cogent Biosciences, Inc. | 5.35B | 2.56% | 1,349,993 | - |
| 159 | DOCS | Doximity, Inc. | 5.35B | 2.08% | 2,767,921 | 655.57M |
| 160 | STVN | Stevanato Group S.p.A. | 5.30B | 0.99% | 204,814 | 1.40B |
| 161 | PTCT | PTC Therapeutics, Inc. | 5.30B | 1.46% | 533,790 | 1.01B |
| 162 | TFX | Teleflex Incorporated | 5.28B | 0.37% | 221,601 | 2.25B |
| 163 | CRSP | CRISPR Therapeutics AG | 5.23B | 7.20% | 997,037 | 13.39M |
| 164 | MMSI | Merit Medical Systems, Inc. | 5.20B | 2.19% | 302,381 | 1.58B |
| 165 | SHC | Sotera Health Company | 5.17B | 1.60% | 730,341 | 1.22B |
| 166 | SRRK | Scholar Rock Holding Corporation | 5.15B | 0.12% | 645,164 | - |
| 167 | DFTX | Definium Therapeutics, Inc. | 5.09B | 10.77% | 1,880,477 | - |
| 168 | WAY | Waystar Holding Corp. | 5.05B | -0.53% | 658,920 | 1.21B |
| 169 | TVTX | Travere Therapeutics, Inc. | 4.93B | 0.48% | 536,919 | 591.33M |
| 170 | LFST | LifeStance Health Group, Inc. | 4.74B | 2.90% | 936,363 | 1.58B |
| 171 | CON | Concentra Group Holdings Parent, Inc. | 4.74B | 1.53% | 422,874 | 2.29B |
| 172 | OPCH | Option Care Health, Inc. | 4.65B | 0.08% | 3,431,323 | 5.69B |
| 173 | BLLN | BillionToOne, Inc. | 4.62B | 2.55% | 226,832 | 397.41M |
| 174 | DNTH | Dianthus Therapeutics, Inc. | 4.61B | 0.02% | 404,724 | 1.90M |
| 175 | ITGR | Integer Holdings Corporation | 4.30B | -0.02% | 906,255 | 1.84B |
| 176 | HTFL | HeartFlow, Inc. | 4.28B | 3.42% | 488,490 | 212.07M |
| 177 | EWTX | Edgewise Therapeutics, Inc. | 4.27B | 0.23% | 420,319 | - |
| 178 | INDV | Indivior Pharmaceuticals, Inc. | 4.25B | 1.55% | 504,507 | 1.33B |
| 179 | ADPT | Adaptive Biotechnologies Corporation | 4.23B | 1.49% | 972,898 | 308.08M |
| 180 | LIVN | LivaNova PLC | 4.22B | 0.86% | 163,396 | 1.47B |
| 181 | ABCL | AbCellera Biologics Inc. | 4.07B | 4.41% | 3,431,219 | 66.17M |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.01B | 5.00% | 867,080 | 10.35M |
| 183 | ICUI | ICU Medical, Inc. | 3.98B | 1.29% | 81,391 | 2.16B |
| 184 | TNGX | Tango Therapeutics, Inc. | 3.96B | 4.10% | 1,795,198 | 53.81M |
| 185 | TLX | Telix Pharmaceuticals Limited | 3.84B | 2.09% | 204,465 | 890.79M |
| 186 | PLSE | Pulse Biosciences, Inc. | 3.75B | 5.24% | 192,682 | 1.19M |
| 187 | RGC | Regencell Bioscience Holdings Limited | 3.67B | -3.01% | 87,195 | - |
| 188 | NVST | Envista Holdings Corporation | 3.66B | 0.22% | 1,213,831 | 2.86B |
| 189 | VCYT | Veracyte, Inc. | 3.66B | 4.31% | 405,477 | 561.90M |
| 190 | LEGN | Legend Biotech Corporation | 3.63B | 0.21% | 884,270 | 1.27B |
| 191 | OGN | Organon & Co. | 3.63B | 0.40% | 2,628,782 | 6.13B |
| 192 | NHC | National HealthCare Corporation | 3.57B | 1.23% | 39,690 | 1.56B |
| 193 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.57B | 4.52% | 709,004 | -665.00K |
| 194 | XENE | Xenon Pharmaceuticals Inc. | 3.54B | 1.05% | 670,094 | 7.50M |
| 195 | IDYA | IDEAYA Biosciences, Inc. | 3.50B | 0.72% | 425,298 | 234.13M |
| 196 | PBLS | Parabilis Medicines, Inc. | 3.46B | -0.36% | 653,096 | 148.00K |
| 197 | IRTC | iRhythm Holdings, Inc. | 3.43B | 1.39% | 235,567 | 825.34M |
| 198 | ACAD | Acadia Pharmaceuticals Inc. | 3.41B | 1.12% | 796,823 | 1.14B |
| 199 | CELC | Celcuity Inc. | 3.34B | 0.57% | 733,821 | - |
| 200 | VKTX | Viking Therapeutics, Inc. | 3.33B | 2.99% | 3,115,885 | - |
| 201 | CDNA | CareDx, Inc. | 3.31B | 2.89% | 591,315 | 458.09M |
| 202 | ARQT | Arcutis Biotherapeutics, Inc. | 3.31B | 7.51% | 1,112,693 | 463.98M |
| 203 | TARS | Tarsus Pharmaceuticals, Inc. | 3.22B | 1.48% | 262,398 | 606.33M |
| 204 | WRBY | Warby Parker Inc. | 3.13B | 1.52% | 915,554 | 911.61M |
| 205 | DYN | Dyne Therapeutics, Inc. | 3.12B | 2.08% | 2,133,972 | - |
| 206 | DNLI | Denali Therapeutics Inc. | 3.10B | 4.02% | 650,706 | 3.60M |
| 207 | RCUS | Arcus Biosciences, Inc. | 3.09B | 1.89% | 447,477 | 117.00M |
| 208 | ELVN | Enliven Therapeutics, Inc. | 3.03B | 1.82% | 548,276 | - |
| 209 | ZLAB | Zai Lab Limited | 2.84B | 1.85% | 837,612 | 449.61M |
| 210 | ATRC | AtriCure, Inc. | 2.81B | 4.45% | 279,432 | 569.62M |
| 211 | PGEN | Precigen, Inc. | 2.76B | 1.58% | 2,348,988 | 85.72M |
| 212 | ACHC | Acadia Healthcare Company, Inc. | 2.74B | 3.16% | 681,889 | 3.37B |
| 213 | TMDX | TransMedics Group, Inc. | 2.73B | -0.48% | 421,040 | 668.47M |
| 214 | AVAH | Aveanna Healthcare Holdings Inc. | 2.68B | 0.37% | 786,662 | 2.60B |
| 215 | PRVA | Privia Health Group, Inc. | 2.66B | 3.12% | 704,087 | 2.36B |
| 216 | NEOG | Neogen Corporation | 2.61B | 1.96% | 1,338,987 | 884.00M |
| 217 | GRDN | Guardian Pharmacy Services, Inc. | 2.59B | -1.56% | 189,341 | 1.46B |
| 218 | CLOV | Clover Health Investments, Corp. | 2.58B | 6.11% | 8,778,677 | 2.48B |
| 219 | BEAM | Beam Therapeutics Inc. | 2.57B | 4.45% | 1,091,914 | 156.04M |
| 220 | NAMS | NewAmsterdam Pharma Company N.V. | 2.56B | 0.85% | 784,592 | 7.12M |
| 221 | MBX | MBX Biosciences, Inc. | 2.56B | -0.20% | 275,672 | - |
| 222 | SUPN | Supernus Pharmaceuticals, Inc. | 2.50B | 2.02% | 419,034 | 830.44M |
| 223 | LQDA | Liquidia Corporation | 2.49B | -0.70% | 2,525,343 | 450.91M |
| 224 | BKD | Brookdale Senior Living Inc. | 2.47B | -5.19% | 10,433,538 | 2.93B |
| 225 | HCM | HUTCHMED (China) Limited | 2.47B | 2.71% | 42,850 | 549.12M |
| 226 | IRON | Disc Medicine, Inc. | 2.40B | 2.74% | 381,725 | - |
| 227 | NRIX | Nurix Therapeutics, Inc. | 2.37B | 2.77% | 736,743 | 36.77M |
| 228 | CLDX | Celldex Therapeutics, Inc. | 2.35B | 2.32% | 536,087 | 158.00K |
| 229 | SLS | SELLAS Life Sciences Group, Inc. | 2.35B | 3.37% | 2,764,763 | - |
| 230 | HRMY | Harmony Biosciences Holdings, Inc. | 2.35B | 1.92% | 262,315 | 959.90M |
| 231 | ADMA | ADMA Biologics, Inc. | 2.30B | -0.39% | 1,277,546 | 512.28M |
| 232 | PBH | Prestige Consumer Healthcare Inc. | 2.30B | 1.57% | 169,240 | 1.10B |
| 233 | BHC | Bausch Health Companies Inc. | 2.27B | 0.66% | 660,045 | 10.85B |
| 234 | RXRX | Recursion Pharmaceuticals, Inc. | 2.27B | 7.09% | 24,769,695 | 54.86M |
| 235 | UFPT | UFP Technologies, Inc. | 2.25B | 1.19% | 66,369 | 631.64M |
| 236 | AUPH | Aurinia Pharmaceuticals Inc. | 2.24B | 3.95% | 498,690 | 311.51M |
| 237 | PHVS | Pharvaris N.V. | 2.23B | 2.25% | 358,752 | - |
| 238 | IMNM | Immunome, Inc. | 2.23B | 1.61% | 540,515 | 4.02M |
| 239 | BFLY | Butterfly Network, Inc. | 2.20B | 3.11% | 2,648,166 | 112.14M |
| 240 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.19B | 3.38% | 960,755 | 940.61M |
| 241 | VERA | Vera Therapeutics, Inc. | 2.15B | 0.30% | 392,373 | - |
| 242 | PGNY | Progyny, Inc. | 2.15B | 0.49% | 358,816 | 1.31B |
| 243 | PRGO | Perrigo Company plc | 2.14B | 6.28% | 2,622,995 | 4.14B |
| 244 | MD | Pediatrix Medical Group, Inc. | 2.13B | 2.36% | 111,160 | 1.95B |
| 245 | NVAX | Novavax, Inc. | 2.12B | 16.89% | 14,378,127 | 413.80M |
| 246 | AXGN | Axogen, Inc. | 2.12B | -0.06% | 552,482 | 251.17M |
| 247 | NEO | NeoGenomics, Inc. | 2.11B | 2.53% | 714,214 | 766.30M |
| 248 | VRDN | Viridian Therapeutics, Inc. | 2.11B | 1.36% | 503,240 | 71.13M |
| 249 | ADUS | Addus HomeCare Corporation | 2.10B | 0.32% | 48,201 | 1.48B |
| 250 | VCEL | Vericel Corporation | 2.07B | 1.00% | 246,363 | 306.30M |
| 251 | SDGR | Schrödinger, Inc. | 2.06B | 4.32% | 1,313,265 | 259.04M |
| 252 | ALVO | Alvotech | 2.06B | 1.59% | 465,451 | 494.61M |
| 253 | MLYS | Mineralys Therapeutics, Inc. | 2.05B | 3.53% | 490,428 | - |
| 254 | TRLV | Trulieve Cannabis Corp. | 2.04B | 2.31% | 645,728 | 1.14B |
| 255 | ADRX | ADARx Pharmaceuticals, Inc. | 2.03B | 2.29% | 522,503 | 6.13M |
| 256 | WGS | GeneDx Holdings Corp. | 2.02B | 0.10% | 208,309 | 454.43M |
| 257 | INSP | Inspire Medical Systems, Inc. | 2.01B | 4.06% | 277,621 | 898.74M |
| 258 | PVLA | Palvella Therapeutics, Inc. | 2.00B | 5.48% | 96,932 | - |
| 259 | VIR | Vir Biotechnology, Inc. | 1.98B | 5.49% | 1,213,096 | 303.23M |
| 260 | FTRE | Fortrea Holdings Inc. | 1.97B | 1.50% | 455,962 | 2.68B |
| 261 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.94B | 3.74% | 952,321 | 208.78M |
| 262 | ASTH | Astrana Health, Inc. | 1.93B | 4.91% | 164,217 | 3.84B |
| 263 | LKFT | Lakefront Biotherapeutics NV | 1.92B | 0.51% | 137,848 | 1.13B |
| 264 | XERS | Xeris Biopharma Holdings, Inc. | 1.92B | 3.58% | 1,473,793 | 335.41M |
| 265 | AGIO | Agios Pharmaceuticals, Inc. | 1.90B | -0.25% | 383,123 | 98.34M |
| 266 | SRPT | Sarepta Therapeutics, Inc. | 1.89B | -1.48% | 1,292,439 | 1.97B |
| 267 | MESO | Mesoblast Limited | 1.88B | 3.93% | 128,188 | 120.25M |
| 268 | TRVI | Trevi Therapeutics, Inc. | 1.86B | 1.83% | 953,262 | - |
| 269 | ZYME | Zymeworks Inc. | 1.86B | 3.52% | 280,395 | 37.13M |
| 270 | GENB | Generate Biomedicines, Inc. | 1.85B | 3.15% | 557,965 | 26.48M |
| 271 | LMAT | LeMaitre Vascular, Inc. | 1.85B | 1.37% | 63,478 | 262.43M |
| 272 | BHVN | Biohaven Ltd. | 1.84B | 2.26% | 827,715 | - |
| 273 | XNCR | Xencor, Inc. | 1.84B | 1.02% | 548,539 | 104.97M |
| 274 | ESTA | Establishment Labs Holdings Inc. | 1.84B | 1.77% | 172,808 | 245.82M |
| 275 | NTLA | Intellia Therapeutics, Inc. | 1.84B | 4.01% | 5,680,921 | 59.51M |
| 276 | URGN | UroGen Pharma Ltd. | 1.84B | 1.57% | 501,594 | 188.73M |
| 277 | GPCR | Structure Therapeutics Inc. | 1.82B | -0.70% | 327,527 | - |
| 278 | SGRY | Surgery Partners, Inc. | 1.81B | 2.57% | 472,599 | 3.37B |
| 279 | ZBIO | Zenas BioPharma, Inc. | 1.79B | 4.80% | 250,252 | 1.00M |
| 280 | SEPN | Septerna, Inc. | 1.79B | 3.83% | 239,788 | 98.88M |
| 281 | XRAY | DENTSPLY SIRONA Inc. | 1.76B | 1.50% | 2,028,287 | 3.64B |
| 282 | ABSI | Absci Corporation | 1.75B | 14.21% | 3,200,735 | 1.56M |
| 283 | NUVB | Nuvation Bio Inc. | 1.75B | 0.61% | 1,436,129 | 169.90M |
| 284 | ALMR | Alamar Biosciences, Inc. | 1.72B | -4.09% | 677,636 | 100.42M |
| 285 | FRNM | Freenome, Inc. | 1.71B | 0.95% | 300,493 | 35.41M |
| 286 | PSNL | Personalis, Inc. | 1.71B | -0.12% | 1,283,707 | 69.67M |
| 287 | NVCR | NovoCure Limited | 1.70B | 2.71% | 541,331 | 699.19M |
| 288 | SNDA | Sonida Senior Living, Inc. | 1.68B | -1.42% | 366,036 | 481.07M |
| 289 | AZTA | Azenta, Inc. | 1.68B | 6.35% | 508,035 | 613.81M |
| 290 | OCUL | Ocular Therapeutix, Inc. | 1.65B | 0.33% | 1,637,458 | 52.06M |
| 291 | CMPS | COMPASS Pathways plc | 1.65B | 3.84% | 1,594,855 | - |
| 292 | ATEC | Alphatec Holdings, Inc. | 1.65B | 3.00% | 788,737 | 815.05M |
| 293 | OMCL | Omnicell, Inc. | 1.64B | 3.30% | 131,365 | 1.25B |
| 294 | BRVE | Braveheart Bio, Inc. | 1.63B | 4.87% | 151,698 | - |
| 295 | STOK | Stoke Therapeutics, Inc. | 1.62B | 4.51% | 226,297 | 27.59M |
| 296 | ARDT | Ardent Health, Inc. | 1.61B | 2.98% | 317,041 | 6.41B |
| 297 | KMTS | Kestra Medical Technologies, Ltd. | 1.60B | 4.38% | 96,918 | 106.73M |
| 298 | ALHC | Alignment Healthcare, Inc. | 1.59B | -12.06% | 21,290,327 | 4.58B |
| 299 | KRSA | Korsana Biosciences, Inc. | 1.58B | 3.61% | 30,416 | - |
| 300 | PAHC | Phibro Animal Health Corporation | 1.58B | 4.06% | 137,042 | 1.52B |
| 301 | ANIP | ANI Pharmaceuticals, Inc. | 1.58B | 2.39% | 278,528 | 978.38M |
| 302 | QURE | uniQure N.V. | 1.58B | 0.89% | 563,163 | 18.67M |
| 303 | ETON | Eton Pharmaceuticals, Inc. | 1.57B | 0.60% | 190,104 | 105.60M |
| 304 | COAG | Hemab Therapeutics Holdings, Inc. | 1.55B | 7.09% | 401,355 | - |
| 305 | INVA | Innoviva, Inc. | 1.54B | 1.82% | 236,885 | 440.00M |
| 306 | RARE | Ultragenyx Pharmaceutical Inc. | 1.52B | 1.18% | 1,726,282 | 717.00M |
| 307 | KLRA | Kailera Therapeutics, Inc. | 1.52B | 16.95% | 1,387,202 | - |
| 308 | IMCR | Immunocore Holdings plc | 1.52B | 1.13% | 201,069 | 430.78M |
| 309 | SNDX | Syndax Pharmaceuticals, Inc. | 1.51B | 0.38% | 780,000 | 252.25M |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.51B | 4.79% | 400,819 | 20.00M |
| 311 | RAPP | Rapport Therapeutics, Inc. | 1.49B | 4.12% | 121,978 | 20.00M |
| 312 | GHRS | GH Research PLC | 1.46B | 3.77% | 84,766 | - |
| 313 | TSHA | Taysha Gene Therapies, Inc. | 1.46B | 0.90% | 2,154,342 | 5.49M |
| 314 | PCRX | Pacira BioSciences, Inc. | 1.45B | -0.21% | 3,766,768 | 746.16M |
| 315 | OMER | Omeros Corporation | 1.43B | 3.48% | 518,561 | 38.42M |
| 316 | HCSG | Healthcare Services Group, Inc. | 1.42B | 0.05% | 155,632 | 1.86B |
| 317 | AMN | AMN Healthcare Services, Inc. | 1.42B | 3.24% | 203,231 | 3.43B |
| 318 | KARD | Kardigan, Inc. | 1.41B | 6.27% | 404,333 | - |
| 319 | NUTX | Nutex Health Inc. | 1.41B | 0.41% | 111,649 | 846.72M |
| 320 | INBX | Inhibrx Biosciences, Inc. | 1.41B | 3.06% | 53,191 | 1.30M |
| 321 | TYRA | Tyra Biosciences, Inc. | 1.40B | 2.10% | 274,627 | - |
| 322 | AGL | agilon health, inc. | 1.40B | -1.50% | 107,275 | 5.92B |
| 323 | CERT | Certara, Inc. | 1.40B | 6.31% | 3,090,493 | 421.75M |
| 324 | NKTR | Nektar Therapeutics | 1.40B | 0.51% | 516,918 | 54.59M |
| 325 | PNTG | The Pennant Group, Inc. | 1.40B | -0.74% | 167,481 | 1.10B |
| 326 | ANAB | AnaptysBio, Inc. | 1.38B | -0.32% | 254,339 | 106.09M |
| 327 | DMRA | Damora Therapeutics, Inc. | 1.34B | 5.50% | 185,506 | - |
| 328 | DRTS | Alpha Tau Medical Ltd. | 1.33B | 3.07% | 258,024 | - |
| 329 | AAPG | Ascentage Pharma Group International | 1.33B | 0.55% | 973 | 94.61M |
| 330 | CNMD | CONMED Corporation | 1.32B | -2.08% | 165,760 | 1.37B |
| 331 | OMDA | Omada Health, Inc. | 1.32B | 3.46% | 264,314 | 309.76M |
| 332 | USPH | U.S. Physical Therapy, Inc. | 1.27B | 1.96% | 80,353 | 804.27M |
| 333 | ORIC | ORIC Pharmaceuticals, Inc. | 1.26B | 0.75% | 782,451 | - |
| 334 | SVRA | Savara Inc. | 1.26B | 2.28% | 721,389 | - |
| 335 | REPL | Replimune Group, Inc. | 1.25B | 2.11% | 1,071,022 | - |
| 336 | NBTX | Nanobiotix S.A. | 1.25B | 3.76% | 71,479 | 13.15M |
| 337 | INNV | InnovAge Holding Corp. | 1.25B | 0.66% | 158,960 | 989.71M |
| 338 | LBRX | LB Pharmaceuticals Inc | 1.21B | 8.52% | 415,252 | - |
| 339 | CRON | Cronos Group Inc. | 1.19B | 0.16% | 297,318 | 179.09M |
| 340 | VOR | Vor Biopharma Inc. | 1.17B | 3.61% | 839,152 | - |
| 341 | GDRX | GoodRx Holdings, Inc. | 1.17B | 1.93% | 321,996 | 785.23M |
| 342 | BCAX | Bicara Therapeutics Inc. | 1.17B | 2.14% | 432,405 | - |
| 343 | JANX | Janux Therapeutics, Inc. | 1.15B | 1.24% | 750,331 | 24.00M |
| 344 | AVLN | Avalyn Pharma Inc. | 1.14B | 0.33% | 151,366 | - |
| 345 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.14B | 3.68% | 132,535 | 730.02M |
| 346 | IRMD | IRADIMED CORPORATION | 1.12B | 1.62% | 42,620 | 86.34M |
| 347 | TRAX | First Tracks Biotherapeutics, Inc. | 1.11B | -2.81% | 640,734 | - |
| 348 | HROW | Harrow, Inc. | 1.10B | -3.90% | 1,129,355 | 275.59M |
| 349 | BVS | Bioventus Inc. | 1.09B | 1.73% | 130,753 | 581.85M |
| 350 | STAA | STAAR Surgical Company | 1.09B | -3.26% | 169,469 | 339.59M |
| 351 | TNDM | Tandem Diabetes Care, Inc. | 1.08B | -1.37% | 839,404 | 1.04B |
| 352 | IART | Integra LifeSciences Holdings Corporation | 1.06B | 1.19% | 460,424 | 1.65B |
| 353 | CSTL | Castle Biosciences, Inc. | 1.05B | 2.11% | 99,022 | 357.28M |
| 354 | AHG | Akso Health Group | 1.05B | 7.46% | 10,048 | 13.83M |
| 355 | PRCT | PROCEPT BioRobotics Corporation | 1.05B | 2.12% | 434,602 | 337.34M |
| 356 | TDOC | Teladoc Health, Inc. | 1.05B | 3.97% | 2,613,228 | 2.49B |
| 357 | MNKD | MannKind Corporation | 1.04B | -5.26% | 2,964,717 | 393.63M |
| 358 | AORT | Artivion, Inc. | 1.04B | 0.66% | 160,838 | 471.47M |
| 359 | LTGO | Latigo Biotherapeutics, Inc. | 1.03B | 5.54% | 72,320 | - |
| 360 | MGTX | MeiraGTx Holdings plc | 1.03B | 2.29% | 261,506 | 397.50M |
| 361 | ENOV | Enovis Corporation | 1.03B | 2.47% | 407,534 | 2.30B |
| 362 | ANL | Adlai Nortye Group Ltd. | 1.03B | 3.09% | 243,538 | 18.06M |
| 363 | OPK | OPKO Health, Inc. | 1.03B | 0.36% | 745,010 | 587.90M |
| 364 | LMRI | Lumexa Imaging Holdings, Inc. | 1.02B | 2.42% | 129,733 | 1.04B |
| 365 | HSTM | HealthStream, Inc. | 1.01B | 1.76% | 73,060 | 321.12M |
| 366 | CGEM | Cullinan Therapeutics, Inc. | 1.00B | 0.97% | 297,895 | - |
| 367 | AKTS | Aktis Oncology, Inc. | 1.00B | 1.35% | 192,716 | 10.06M |
| 368 | IMTX | Immatics N.V. | 996.47M | -1.09% | 1,054,296 | 47.65M |
| 369 | SPTX | Seaport Therapeutics, Inc. | 968.90M | 1.06% | 70,351 | - |
| 370 | ANRO | Alto Neuroscience, Inc. | 962.61M | 2.08% | 303,685 | - |
| 371 | KURA | Kura Oncology, Inc. | 937.20M | 0.14% | 904,710 | 77.23M |
| 372 | ALMS | Alumis Inc. | 930.64M | 3.16% | 790,107 | 7.40M |
| 373 | JBIO | Jade Biosciences, Inc. | 925.98M | 2.90% | 416,943 | - |
| 374 | RIGL | Rigel Pharmaceuticals, Inc. | 924.65M | 1.60% | 190,534 | 276.79M |
| 375 | MLTX | MoonLake Immunotherapeutics | 922.56M | 2.46% | 1,394,110 | - |
| 376 | ODTX | Odyssey Therapeutics, Inc. | 920.51M | 6.02% | 197,153 | 99.00K |
| 377 | BBNX | Beta Bionics, Inc. | 914.39M | -0.34% | 295,848 | 119.01M |
| 378 | QDEL | QuidelOrtho Corporation | 912.05M | 7.17% | 1,631,093 | 2.67B |
| 379 | CBLL | CeriBell, Inc. | 889.99M | 0.17% | 124,690 | 101.96M |
| 380 | CRVS | Corvus Pharmaceuticals, Inc. | 883.69M | 2.89% | 585,287 | - |
| 381 | GLUE | Monte Rosa Therapeutics, Inc. | 880.43M | - | 616,523 | 28.73M |
| 382 | DNA | Ginkgo Bioworks Holdings, Inc. | 878.12M | 14.99% | 3,677,822 | 132.42M |
| 383 | SLBT | SL Science Holding Limited | 872.51M | 0.66% | 17,232 | 3.27M |
| 384 | HELP | Helus Pharma Inc. | 869.42M | 11.01% | 1,193,047 | - |
| 385 | SIBN | SI-BONE, Inc. | 860.96M | 1.86% | 195,659 | 213.60M |
| 386 | SANA | Sana Biotechnology, Inc. | 853.18M | 2.15% | 2,173,581 | - |
| 387 | ABUS | Arbutus Biopharma Corporation | 842.83M | 1.91% | 1,653,353 | 181.72M |
| 388 | SGP | SpyGlass Pharma, Inc. | 836.70M | 1.60% | 38,392 | - |
| 389 | AVBP | ArriVent BioPharma, Inc. | 833.30M | 1.14% | 1,116,717 | - |
| 390 | GMRS | GMR Solutions Inc. | 823.07M | 0.47% | 800,545 | 5.88B |
| 391 | ARDX | Ardelyx, Inc. | 819.83M | 0.61% | 1,443,455 | 450.89M |
| 392 | INMD | InMode Ltd. | 815.36M | 0.75% | 105,057 | 374.63M |
| 393 | OBX | Obsidian Therapeutics, Inc. | 812.31M | 7.43% | 341,116 | - |
| 394 | AHCO | AdaptHealth Corp. | 804.46M | -0.58% | 606,724 | 3.36B |
| 395 | APMD | Apnimed, Inc. | 795.36M | 4.86% | 171,186 | 115.12M |
| 396 | GERN | Geron Corporation | 793.45M | 1.23% | 2,685,482 | 204.56M |
| 397 | IMMX | Immix Biopharma, Inc. | 782.60M | 1.61% | 650,932 | - |
| 398 | VREX | Varex Imaging Corporation | 777.84M | -0.08% | 134,103 | 865.00M |
| 399 | ANNX | Annexon, Inc. | 774.43M | 2.12% | 726,786 | - |
| 400 | ATTO | Attovia Therapeutics, Inc. | 768.77M | 3.25% | 97,176 | 1.80M |
| 401 | VSTM | Verastem, Inc. | 760.28M | 3.51% | 1,956,026 | 87.53M |
| 402 | LXRX | Lexicon Pharmaceuticals, Inc. | 758.65M | -3.12% | 1,354,198 | 41.47M |
| 403 | ACHV | Achieve Life Sciences, Inc. | 758.39M | 2.50% | 569,629 | - |
| 404 | FDMT | 4D Molecular Therapeutics, Inc. | 756.85M | 7.87% | 542,270 | 92.01M |
| 405 | CADL | Candel Therapeutics, Inc. | 755.24M | 2.17% | 431,221 | - |
| 406 | GYRE | Gyre Therapeutics, Inc. | 746.48M | 4.14% | 43,478 | 109.82M |
| 407 | SLDB | Solid Biosciences Inc. | 744.14M | 1.76% | 388,064 | - |
| 408 | AVTX | Avalo Therapeutics, Inc. | 732.85M | 1.75% | 327,135 | 59.00K |
| 409 | DSGN | Design Therapeutics, Inc. | 730.33M | 1.57% | 199,608 | - |
| 410 | COLL | Collegium Pharmaceutical, Inc. | 727.46M | 1.06% | 247,691 | 808.21M |
| 411 | PACB | Pacific Biosciences of California, Inc. | 727.34M | 1.74% | 10,485,613 | 159.27M |
| 412 | IVA | Inventiva S.A. | 717.43M | -3.16% | 1,405,885 | 2.81M |
| 413 | PRME | Prime Medicine, Inc. | 706.28M | 10.89% | 6,431,690 | 4.07M |
| 414 | CTKB | Cytek Biosciences, Inc. | 705.81M | 1.31% | 3,003,958 | 206.71M |
| 415 | OLMA | Olema Pharmaceuticals, Inc. | 697.36M | 1.92% | 357,495 | - |
| 416 | OABI | OmniAb, Inc. | 697.15M | 2.90% | 646,574 | 38.46M |
| 417 | STLN | Starling Oncology, Inc. | 687.93M | 9.22% | 706,129 | 587.24M |
| 418 | WVE | Wave Life Sciences, Inc. | 687.70M | 0.58% | 1,022,903 | 65.37M |
| 419 | AURA | Aura Biosciences, Inc. | 687.56M | 1.92% | 422,438 | - |
| 420 | NVCT | Nuvectis Pharma, Inc. | 684.21M | 4.32% | 61,244 | - |
| 421 | MDXG | MiMedx Group, Inc. | 682.89M | 1.41% | 179,431 | 355.17M |
| 422 | PHAR | Pharming Group N.V. | 679.22M | 1.42% | 3,039 | 366.48M |
| 423 | ZVRA | Zevra Therapeutics, Inc. | 674.01M | 3.18% | 339,928 | 136.07M |
| 424 | FTH | Faeth Therapeutics, Inc. | 671.59M | 1.48% | 134,734 | - |
| 425 | PHR | Phreesia, Inc. | 665.40M | 0.56% | 199,339 | 507.79M |
| 426 | AVR | Anteris Technologies Global Corp. | 662.96M | 2.56% | 777,192 | 2.24M |
| 427 | CBIO | Crescent Biopharma, Inc. | 646.51M | 6.98% | 249,176 | 11.88M |
| 428 | IRWD | Ironwood Pharmaceuticals, Inc. | 646.09M | 1.03% | 1,065,522 | 389.32M |
| 429 | CLYM | Climb Bio, Inc. | 638.12M | 2.30% | 338,687 | - |
| 430 | SGMT | Sagimet Biosciences Inc. | 630.38M | -0.34% | 425,358 | - |
| 431 | SOPH | SOPHiA GENETICS SA | 629.95M | 1.37% | 231,702 | 86.17M |
| 432 | AQST | Aquestive Therapeutics, Inc. | 608.73M | 1.89% | 1,168,138 | 54.09M |
| 433 | SLN | Silence Therapeutics plc | 608.72M | 6.20% | 517,852 | 615.00K |
| 434 | FLGT | Fulgent Genetics, Inc. | 596.12M | 4.06% | 118,396 | 323.93M |
| 435 | STTK | Shattuck Labs, Inc. | 595.15M | 4.77% | 507,344 | 1.00M |
| 436 | WEAV | Weave Communications, Inc. | 589.99M | -0.20% | 3,086,338 | 257.79M |
| 437 | PHAT | Phathom Pharmaceuticals, Inc. | 575.87M | 1.68% | 418,777 | 239.66M |
| 438 | CRMD | CorMedix Inc. | 572.89M | 0.41% | 530,818 | 462.25M |
| 439 | ACRS | Aclaris Therapeutics, Inc. | 571.13M | 2.37% | 2,343,104 | 8.22M |
| 440 | ETRA | Electra Therapeutics, Inc. | 568.51M | -0.90% | 119,841 | - |
| 441 | DBVT | DBV Technologies S.A. | 564.38M | 0.84% | 249,280 | 5.04M |
| 442 | KIDS | OrthoPediatrics Corp. | 560.58M | -1.33% | 77,760 | 252.72M |
| 443 | CTMX | CytomX Therapeutics, Inc. | 553.46M | 2.83% | 2,266,372 | 18.30M |
| 444 | BLSM | BlossomHill Therapeutics, Inc. | 550.04M | 2.52% | 73,952 | - |
| 445 | EVO | Evotec SE | 548.74M | -2.23% | 27,327 | 819.47M |
| 446 | MNPR | Monopar Therapeutics Inc. | 546.44M | -3.06% | 61,581 | - |
| 447 | NGNE | Neurogene Inc. | 537.71M | 1.40% | 277,693 | 925.00K |
| 448 | DRUG | Bright Minds Biosciences Inc. | 537.32M | 5.51% | 59,125 | - |
| 449 | VALN | Valneva SE | 532.38M | 0.88% | 3,729 | 163.30M |
| 450 | RGNX | REGENXBIO Inc. | 531.41M | -0.49% | 500,508 | 174.48M |
| 451 | DCTH | Delcath Systems, Inc. | 531.24M | 1.80% | 100,126 | 95.42M |
| 452 | SSII | SS Innovations International, Inc. | 531.02M | 0.76% | 26,076 | 52.40M |
| 453 | PBYI | Puma Biotechnology, Inc. | 530.40M | 3.06% | 214,123 | 231.24M |
| 454 | PROK | ProKidney Corp. | 524.53M | 4.52% | 680,744 | 818.00K |
| 455 | OCS | Oculis Holding AG | 520.09M | -2.71% | 87,681 | 1.45M |
| 456 | CTNM | Contineum Therapeutics, Inc. | 518.04M | 4.48% | 526,268 | - |
| 457 | TLRY | Tilray Brands, Inc. | 516.25M | -1.95% | 4,662,695 | 963.10M |
| 458 | RZLT | Rezolute, Inc. | 513.47M | 5.50% | 1,311,408 | - |
| 459 | EOLS | Evolus, Inc. | 512.55M | -0.51% | 273,545 | 316.49M |
| 460 | ALT | Altimmune, Inc. | 511.58M | 1.15% | 1,563,085 | 31.00K |
| 461 | TCMD | Tactile Systems Technology, Inc. | 505.83M | 0.95% | 54,786 | 350.31M |
| 462 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 463 | ALLO | Allogene Therapeutics, Inc. | 502.69M | 3.93% | 9,197,076 | 4.64M |
| 464 | ARVN | Arvinas, Inc. | 501.84M | 2.20% | 293,598 | 316.70M |
| 465 | MASS | 908 Devices Inc. | 496.42M | 3.98% | 163,678 | 60.84M |
| 466 | ANGO | AngioDynamics, Inc. | 494.56M | 4.72% | 1,459,481 | 325.38M |
| 467 | EPRX | Eupraxia Pharmaceuticals Inc. | 491.03M | -1.12% | 795,009 | - |
| 468 | MPLT | MapLight Therapeutics, Inc. | 486.29M | -4.37% | 236,484 | - |
| 469 | TKNO | Alpha Teknova, Inc. | 481.05M | 6.16% | 132,068 | 43.70M |
| 470 | OVID | Ovid Therapeutics Inc. | 480.43M | 5.13% | 921,157 | 1.58M |
| 471 | SGHT | Sight Sciences, Inc. | 480.37M | 2.95% | 154,067 | 83.38M |
| 472 | ASMB | Assembly Biosciences, Inc. | 479.49M | 3.20% | 69,030 | 74.85M |
| 473 | AUTL | Autolus Therapeutics plc | 479.09M | 1.69% | 1,085,370 | 117.39M |
| 474 | YDES | YD Bio Limited | 477.40M | 16.41% | 186,078 | 1.24M |
| 475 | BWAY | BrainsWay Ltd. | 475.05M | 2.53% | 65,924 | 60.70M |
| 476 | SENS | Senseonics Holdings, Inc. | 471.11M | -1.22% | 267,905 | 48.55M |
| 477 | ENTX | Entera Bio Ltd. | 465.75M | 7.60% | 1,303,390 | 42.00K |
| 478 | KMDA | Kamada Ltd. | 463.58M | 3.79% | 49,415 | 191.85M |
| 479 | EVH | Evolent Health, Inc. | 462.41M | 3.28% | 573,935 | 2.10B |
| 480 | CERS | Cerus Corporation | 461.49M | 0.44% | 514,450 | 221.55M |
| 481 | PRTA | Prothena Corporation plc | 459.98M | 4.07% | 738,114 | 54.53M |
| 482 | TECX | Tectonic Therapeutic, Inc. | 458.24M | 3.03% | 52,033 | - |
| 483 | CAPR | Capricor Therapeutics, Inc. | 455.23M | -2.25% | 1,307,837 | 11.13M |
| 484 | EDIT | Editas Medicine, Inc. | 451.53M | 3.52% | 2,086,045 | 47.01M |
| 485 | DMAC | DiaMedica Therapeutics Inc. | 449.47M | 4.06% | 81,077 | - |
| 486 | NRC | NRC Health | 448.92M | -0.61% | 23,791 | 140.00M |
| 487 | AGMB | AgomAb Therapeutics NV | 446.68M | -1.63% | 71,073 | - |
| 488 | NPCE | NeuroPace, Inc. | 431.46M | 1.45% | 39,917 | 106.99M |
| 489 | SPRY | ARS Pharmaceuticals, Inc. | 425.63M | -6.14% | 703,579 | 116.93M |
| 490 | CTEV | Claritev Corporation | 421.82M | 2.30% | 61,948 | 994.67M |
| 491 | MYGN | Myriad Genetics, Inc. | 417.99M | 4.05% | 671,428 | 806.60M |
| 492 | AVIR | Atea Pharmaceuticals, Inc. | 413.05M | -0.10% | 84,604 | - |
| 493 | EIKN | Eikon Therapeutics, Inc. | 411.65M | 1.33% | 203,295 | - |
| 494 | RCEL | AVITA Medical, Inc. | 407.31M | -1.20% | 188,472 | 75.63M |
| 495 | GLAS | Glass House Brands Inc. | 407.13M | -2.04% | 1,489,021 | 176.98M |
| 496 | PRLD | Prelude Therapeutics Incorporated | 404.77M | 1.29% | 178,369 | 22.42M |
| 497 | SRTA | Strata Critical Medical, Inc. | 403.41M | 2.01% | 454,704 | 255.98M |
| 498 | KYTX | Kyverna Therapeutics, Inc. | 400.75M | 4.85% | 588,833 | - |
| 499 | GALT | Galectin Therapeutics Inc. | 397.35M | 8.24% | 102,192 | - |
| 500 | CARL | Carlsmed, Inc. | 397.25M | 3.56% | 30,112 | 63.30M |